Skip to main content
  • Print page
  • Bookmark Page

Key Financial Data

Key Data

(m €)
2008 2009 2010 2011 2012
Net Sales 689.64
(100%)		 747.5
(100%)		 728.1
(100%)		 762.0
(100%)		 828.3
(100%)
Operating Income 144.7
(21.0%)		 162.2
(21.7%)		 154.8
(21.3%)		 163.5
(21.5%)		 167.0
(20.2%)
Net Income 100.4
(14.6%)		 110.6
(14.8%)		 108.6
(14.9%)		 116.4
(15.3%)		 118.5
(14.3%)

Net Sales

Net Sales graph

Sales by Business

Sales by Business pie-chart

Pharmaceuticals: Net Sales

Pharmaceutical Sales graph

Key P&L and Cash Flow

(m €)
2008 2009 2010 2011 2012
Net Sales 689.6 747.5 728.1 762.0 828.3
Gross profit
as % of Sales		 467.4
67.8%		 511.9
68.5%		 488.1
67.0%		 502.1
65.9%		 534.7
64.6%
Operating Income
(EBIT) as % of Sales		 144.7
21.0%		 162.2
21.7%		 154.8
21.3%		 163.5
21.5%		 167.0
20.2%
Pretax Income 138.1 152.7 151.0 160.0 160.3
Net Income 100.4 110.6 108.6 116.4 118.5
CASH FLOW 140.3 149.2 135.8 140.7 145.2

Balance Sheet Structure

Balance Sheet Structure chart

Per Share Data

2008 2009 2010 2011 2012
Earnings per share (EPS) 0.511 0.561 0.548 0.584 0.593
Shareholders'equity per share 2.262 2.575 2.896 2.982 3.297
Dividend for share 0.250 0.275 0.275 0.30 0.30
Last updated on:
11/03/13
10:51:21 CET
Delivered by Investis (opens in a new window)